CYLENE PHARMACEUTICALS, INC. — Form D/A
CYLENE PHARMACEUTICALS, INC. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2011-08-11. The offering totals $20.2M, of which $15.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-11
- Form: D/A
- Accession: 0001142536-11-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $20.2M
- Amount sold: $15.6M
- Remaining: $4.5M
- Investors: 18
- Date of first sale: 2010-05-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-143347
Issuer
- Name: CYLENE PHARMACEUTICALS, INC.
- CIK: 0001142536
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5820 NANCY RIDGE DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Phone: 8588755100
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Shaun A Kirkpatrick | Director | San Diego, CA |
| Reinhard J Ambros | Director | Waltham, MA |
| Fred A Middleton | Director | Chapel Hill, NC |
| S. Edward Torres | Director | Durham, NC |
| WILLIAM G RICE | Director | TORONTO, A6 |
| WILLIAM G RICE | Executive Officer | TORONTO, A6 |
| Erich G Platzer, M.D. | Director | San Diego, CA |
| Reinhard J Ambros, Ph.D. | Director | San Diego, CA |
| Peter J Feinstein | Director | San Diego, CA |
| Daniel D Von Hoff, M.D., F.A.C.P. | Director | San Diego, CA |
| William G Rice, Ph.D. | Director | San Diego, CA |
| William G Rice, Ph.D. | Executive Officer | San Diego, CA |
| Erich G Platzer | Director | San Diego, CA |
| Daniel D Von Hoff | Director | San Diego, CA |
Other filings by this issuer (2)
More